Shanghai Haohai Biological Technology Co., Ltd. Proposes Final Dividend for the Year Ended December 31, 2019, Payable on or Before August 31, 2020
March 26, 2020 at 08:26 am EDT
Share
The Board of Shanghai Haohai Biological Technology Co., Ltd. proposed to declare the final dividend of RMB 0.7 (inclusive of tax) per share for the year ended 31 December 2019, totally amounting to RMB 124,491,710.
If the distributiopn of final dividend is approved at the AGM, the Company expects to distribute the dividend within two months after the date of the AGM (expected to be on or before 31 August 2020).
Shanghai Haohai Biological Technology Co., Ltd. is a China-based company principally engaged in biological technology-related businesses. The businesses of the Company include the manufacture and sales of biological and medical hyaluronate, the research and development of biological engineering and pharmaceutical products and the provision of related services. Its products include orthopedics products, medical aesthetics and wound care products, ophthalmology products and anti-adhesion and hemostasis products, among others. Orthopedics products include sodium hyaluronate injection, medical chitosan and medical sodium hyaluronate gel. Medical aesthetics and wound care products include recombinant human epidermal growth factor (rhEGF), among others. Ophthalmology products include ophthalmic viscoelastic devices and lubricant eye drops. Anti-adhesion and hemostasis products include medical collagen sponges, among others. The Company mainly operates businesses in Mainland China.
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. 
